EA202190317A1 - Лекарственный препарат для наружного применения - Google Patents

Лекарственный препарат для наружного применения

Info

Publication number
EA202190317A1
EA202190317A1 EA202190317A EA202190317A EA202190317A1 EA 202190317 A1 EA202190317 A1 EA 202190317A1 EA 202190317 A EA202190317 A EA 202190317A EA 202190317 A EA202190317 A EA 202190317A EA 202190317 A1 EA202190317 A1 EA 202190317A1
Authority
EA
Eurasian Patent Office
Prior art keywords
external use
drug
medicament
prevention
treatment
Prior art date
Application number
EA202190317A
Other languages
English (en)
Inventor
Масаясу Танака
Йосихиро Оямада
Йосинори Такада
Original Assignee
Сумитомо Дайниппон Фарма Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сумитомо Дайниппон Фарма Ко., Лтд. filed Critical Сумитомо Дайниппон Фарма Ко., Лтд.
Publication of EA202190317A1 publication Critical patent/EA202190317A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к лекарственному средству для лечения и/или профилактики боли, более конкретно к лекарственному препарату для наружного применения для лечения и/или предотвращения периферической невропатической боли, лекарственному препарату, содержащему в качестве активного ингредиента N2-{[1-этил-6-(4-метилфенокси)-1H-бензимидазол-2-ил]метил}-L-аланинамид.
EA202190317A 2018-07-19 2019-07-18 Лекарственный препарат для наружного применения EA202190317A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018136147 2018-07-19
PCT/JP2019/028251 WO2020017585A1 (ja) 2018-07-19 2019-07-18 外用製剤

Publications (1)

Publication Number Publication Date
EA202190317A1 true EA202190317A1 (ru) 2021-04-20

Family

ID=69165160

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190317A EA202190317A1 (ru) 2018-07-19 2019-07-18 Лекарственный препарат для наружного применения

Country Status (12)

Country Link
US (1) US11925621B2 (ru)
EP (1) EP3824887A4 (ru)
JP (1) JP7391848B2 (ru)
KR (1) KR20210034615A (ru)
CN (1) CN112423749A (ru)
AU (1) AU2019306705A1 (ru)
BR (1) BR112021000183A8 (ru)
CA (1) CA3105465A1 (ru)
EA (1) EA202190317A1 (ru)
IL (1) IL280118A (ru)
MX (1) MX2021000714A (ru)
WO (1) WO2020017585A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2380881T (lt) * 2008-12-26 2017-04-10 Sumitomo Dainippon Pharma Co., Ltd. Naujas biciklinis heterociklinis junginys
CN116615184A (zh) 2020-12-23 2023-08-18 住友制药株式会社 口服固体制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030060904A (ko) * 2000-10-06 2003-07-16 뉴로젠 코포레이션 Ｃｒｆ 수용체 조절자로서 벤즈이미다졸 및 인돌 유도체
WO2002042278A2 (en) * 2000-11-21 2002-05-30 Vertex Pharmaceuticals Incorporated Imidazole and benzimidazole caspase inhibitors and uses thereof
LT2380881T (lt) 2008-12-26 2017-04-10 Sumitomo Dainippon Pharma Co., Ltd. Naujas biciklinis heterociklinis junginys
JP5667934B2 (ja) 2010-06-28 2015-02-12 大日本住友製薬株式会社 新規２環性複素環化合物からなる医薬

Also Published As

Publication number Publication date
BR112021000183A2 (pt) 2021-06-01
BR112021000183A8 (pt) 2022-12-06
EP3824887A1 (en) 2021-05-26
US20210322385A1 (en) 2021-10-21
MX2021000714A (es) 2021-03-25
US11925621B2 (en) 2024-03-12
CA3105465A1 (en) 2020-01-23
IL280118A (en) 2021-03-01
AU2019306705A1 (en) 2021-01-28
CN112423749A (zh) 2021-02-26
KR20210034615A (ko) 2021-03-30
JP7391848B2 (ja) 2023-12-05
WO2020017585A1 (ja) 2020-01-23
EP3824887A4 (en) 2022-04-13
JPWO2020017585A1 (ja) 2021-08-02

Similar Documents

Publication Publication Date Title
EA202090019A1 (ru) Спироциклические индолины в качестве модуляторов il-17
EA201890654A1 (ru) Терапевтические композиции для лечения вируса иммунодефицита человека
EA202090573A1 (ru) Составы нирапариба
EA201390353A1 (ru) Производное пиразолохинолина
EA201491321A1 (ru) Фторметил-5,6-дигидро-4н-[1,3]оксазины
EA202190960A1 (ru) Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30)
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
EA202190510A1 (ru) Новое лекарственное средство для лечения воспалительной болезни кишечника
EA201890906A1 (ru) ПРОИЗВОДНЫЕ ХИНОКСАЛИНА И ПИРИДОПИРАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
EA202190317A1 (ru) Лекарственный препарат для наружного применения
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
EA201992117A1 (ru) Фармацевтическая комбинация, содержащая понесимод
EA202192483A1 (ru) Лекарственное средство и способ лечения или профилактики осложнений диабета с использованием этого лекарственного средства
PH12017501668A1 (en) Bace1 inhibitors
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
SG11202106163RA (en) Pharmaceutical composition for prevention or treatment of cancer comprising lactobacillus sakei wikim30 as active ingredient
PH12019502261A1 (en) Therapeutic or prophylactic agent for peripheral neuropathies
BR112017016278A2 (pt) agente preventivo e/ou terapêutico de doença imune
EA201991817A1 (ru) Интраназальная композиция, включающая бетагистин
EA201992234A1 (ru) Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
EA201990550A1 (ru) Офтальмологический препарат, включающий азоловое соединение
WO2016072854A3 (en) Pantothenamide analogues
EA201692532A1 (ru) Антимикробные композиции с шипучими веществами